Yesterday, Immobel reported FY25 results in line with our expectations at € 456,4m operating income (internal view) vs € 445,4m KBCSe, +2,5% YoY. The recurring gross margin came in at 19,9% vs. 20,0% KBCSe, +10,2% YoY. The margin recovery is driven by higher exit values in the Belgian residential market. On an underlying net results basis the net margin improved from 1,3% in FY24 to 5,6% in FY25. The € 125,0m bond maturity of June 2026 is covered by the € 202,0m headroom (internal view). The gea...
The tariff war between US and China has eased, but with the Iran conflict and an erratic Trump, uncertainty will continue into 2027. Energy prices have gone ballistic, with gas prices doubling in Europe and has hit the cyclical stocks hard. The highly anticipated AI productivity gains also will have to transpire sooner or later or a US market correction becomes unavoidable. While the macro-economic impact has been limited so far, a prolonged uncertain situation will result in economic damage. We...
Solvac has taken note of the market reaction following the recent publication of Syensqo’s results and outlook Press releaseRegulated information Brussels, March 2, 2026, 7.00 am CET Solvac is closely monitoring the situation and is in close contact with Syensqo’s Board of Directors and management. Solvac is fully mobilised in its role as a long‑term reference shareholder and is acting alongside Syensqo to support the company through this phase. Solvac is a public limited company under Belgian law founded in 1983 and listed on the Euronext Brussels stock exchange under the ISIN code BE0...
Solvac prend acte de la réaction des marchés à la publication récente des résultats et des perspectives de Syensqo Communiqué de PresseInformation réglementée Bruxelles, le 2 mars 2026 – 7h00 CET Solvac suit la situation avec la plus grande attention et est en contact étroit avec le Conseil d’administration et le management de Syensqo. Solvac est pleinement mobilisée dans son rôle d’actionnaire de référence de long terme et agit aux côtés de Syensqo, afin d’accompagner l’entreprise dans cette phase. Solvac est une société anonyme de droit belge fondée en 1983 et ...
Solvac heeft kennisgenomen van de marktreactie op de recente publicatie van de resultaten en vooruitzichten van Syensqo PersberichtGereglementeerde informatie Brussel, 2 maart 2026 – 7u00 CET Solvac volgt de situatie met de grootste aandacht en onderhoudt nauwe contacten met de Raad van Bestuur en het management van Syensqo. Solvac is volledig gemobiliseerd in haar rol als referentieaandeelhouder op lange termijn en handelt samen met Syensqo om de onderneming in deze fase te begeleiden. Solvac is een naamloze vennootschap naar Belgisch recht opgericht in 1983 en genoteerd op Euronext B...
Ackermans & van Haaren: Results capping already strong subsidiary reporting. DPS beat. Fagron: Acquisition of Pharmavit Europe, active in nutraceutical raw materials. Fugro: Patience please. Kendrion: Sees signs of improvement in EU economy. Proximus: 2026 dividend halved, 2028-30 targets a bit better on lower capex. Proximus: 4Q25 in line EBITDA on weaker sales, FCF up; 2026 guidance below on EBITDA. Recticel: Strong FY25 results, CEO transition seen as a negative
Proximus is holding a CMD in Brussels today that we are attending. Ahead of that, it has put out a release with FY26, FY28 guidance, and some long-term (FY30) capex and FCF estimates too. We don’t have all the detail yet, but we outline our initial thoughts in this report, and some commentary on the Q4 results too.
Proximus reported solid 4Q25 results, with the underlying EBITDA of € 437m broadly in line with expectations (kbcse: € 433m, css: € 434m) while the FY25 organic FCF of € 130m came in slightly ahead (kbcse: € 107m, css: € 102m). Although the outlook 2026 was broadly in line, we welcome the lower capex spending of between € 1.20- € 1.25bn (kbcse: € 1.30bn, css: € 1.29bn), resulting in a better than expected FCF guidance for 2026 of up to € 100m (kbcse: € 39m, css: € 24m). By 2030, the group expect...
Aalberts: In-line FY25, but low quality / AMG: 4Q25 beat by 7%; in-line 2026 guidance / Bekaert: In-line 2025, cautious outlook for 2026 to result in c.8% consensus cut / CMB.TECH: A small bit beat but not the full story / Corbion: Dividend sweetener / CTP: Q4 results lighter due to some delays; stronger 2026 outlook / DEME: Strong FY25 numbers and FY26 outlook / Elia Group: Preview FY25 results / SBM Offshore: Another step-up in shareholder return / Syensqo: Substantial miss in 4Q25; FY26 outlo...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.